Literature DB >> 25575565

Abnormal accumulation of desmin in gastrocnemius myofibers of patients with peripheral artery disease: associations with altered myofiber morphology and density, mitochondrial dysfunction and impaired limb function.

Panagiotis Koutakis1, Dimitrios Miserlis1, Sara A Myers2, Julian Kyung-Soo Kim1, Zhen Zhu1, Evlampia Papoutsi1, Stanley A Swanson1, Gleb Haynatzki3, Duy M Ha1, Lauren A Carpenter1, Rodney D McComb4, Jason M Johanning1,5, George P Casale1, Iraklis I Pipinos1,5.   

Abstract

Patients with peripheral artery disease (PAD) develop a myopathy in their ischemic lower extremities, which is characterized by myofiber degeneration, mitochondrial dysfunction and impaired limb function. Desmin, a protein of the cytoskeleton, is central to maintenance of the structure, shape and function of the myofiber and its organelles, especially the mitochondria, and to translation of sarcomere contraction into muscle contraction. In this study, we investigated the hypothesis that disruption of the desmin network occurs in gastrocnemius myofibers of PAD patients and correlates with altered myofiber morphology, mitochondrial dysfunction, and impaired limb function. Using fluorescence microscopy, we evaluated desmin organization and quantified myofiber content in the gastrocnemius of PAD and control patients. Desmin was highly disorganized in PAD but not control muscles and myofiber content was increased significantly in PAD compared to control muscles. By qPCR, we found that desmin gene transcripts were increased in the gastrocnemius of PAD patients as compared with control patients. Increased desmin and desmin gene transcripts in PAD muscles correlated with altered myofiber morphology, decreased mitochondrial respiration, reduced calf muscle strength and decreased walking performance. In conclusion, our studies identified disruption of the desmin system in gastrocnemius myofibers as an index of the myopathy and limitation of muscle function in patients with PAD.
© The Author(s) 2015.

Entities:  

Keywords:  Cytoskeleton; desmin; intermittent claudication; muscle disease; myofiber

Mesh:

Substances:

Year:  2015        PMID: 25575565      PMCID: PMC4374059          DOI: 10.1369/0022155415569348

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  69 in total

Review 1.  Lateral force transmission across costameres in skeletal muscle.

Authors:  Robert J Bloch; Hugo Gonzalez-Serratos
Journal:  Exerc Sport Sci Rev       Date:  2003-04       Impact factor: 6.230

Review 2.  Structure-function considerations of muscle-tendon junctions.

Authors:  John A Trotter
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2002-12       Impact factor: 2.320

Review 3.  Costameres: the Achilles' heel of Herculean muscle.

Authors:  James M Ervasti
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

4.  Gait alterations associated with walking impairment in people with peripheral arterial disease with and without intermittent claudication.

Authors:  M M McDermott; S M Ohlmiller; K Liu; J M Guralnik; G J Martin; W H Pearce; P Greenland
Journal:  J Am Geriatr Soc       Date:  2001-06       Impact factor: 5.562

Review 5.  Desmin cytoskeleton: a potential regulator of muscle mitochondrial behavior and function.

Authors:  Yassemi Capetanaki
Journal:  Trends Cardiovasc Med       Date:  2002-11       Impact factor: 6.677

6.  Abnormal mitochondrial respiration in skeletal muscle in patients with peripheral arterial disease.

Authors:  Iraklis I Pipinos; Victor G Sharov; Alexander D Shepard; Petros V Anagnostopoulos; Asterios Katsamouris; Anastasia Todor; Konstantinos A Filis; Hani N Sabbah
Journal:  J Vasc Surg       Date:  2003-10       Impact factor: 4.268

Review 7.  Desmin myopathy.

Authors:  L G Goldfarb; P Vicart; H H Goebel; M C Dalakas
Journal:  Brain       Date:  2004-01-14       Impact factor: 13.501

8.  Evidence of myofibrillar protein oxidation induced by postischemic reperfusion in isolated rat hearts.

Authors:  Marcella Canton; Irina Neverova; Roberta Menabò; Jennifer Van Eyk; Fabio Di Lisa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-03       Impact factor: 4.733

9.  Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients.

Authors:  Duygu Selcen; Kinji Ohno; Andrew G Engel
Journal:  Brain       Date:  2004-01-07       Impact factor: 13.501

10.  Leg strength in peripheral arterial disease: associations with disease severity and lower-extremity performance.

Authors:  Mary McGrae McDermott; Michael H Criqui; Philip Greenland; Jack M Guralnik; Kiang Liu; William H Pearce; Lloyd Taylor; Cheeling Chan; Lillian Celic; Charles Woolley; Michael P O'Brien; Joseph R Schneider
Journal:  J Vasc Surg       Date:  2004-03       Impact factor: 4.268

View more
  31 in total

1.  A low-cost, wireless near-infrared spectroscopy device detects the presence of lower extremity atherosclerosis as measured by computed tomographic angiography and characterizes walking impairment in peripheral artery disease.

Authors:  Matthew A Fuglestad; Hernan Hernandez; Yue Gao; Henamari Ybay; Molly N Schieber; Katyarina E Brunette; Sara A Myers; George P Casale; Iraklis I Pipinos
Journal:  J Vasc Surg       Date:  2019-08-21       Impact factor: 4.268

Review 2.  Disruption of mitochondrial quality control in peripheral artery disease: New therapeutic opportunities.

Authors:  Cintia B Ueta; Katia S Gomes; Márcio A Ribeiro; Daria Mochly-Rosen; Julio C B Ferreira
Journal:  Pharmacol Res       Date:  2016-11-19       Impact factor: 7.658

3.  Abnormal myofiber morphology and limb dysfunction in claudication.

Authors:  Panagiotis Koutakis; Sara A Myers; Kim Cluff; Duy M Ha; Gleb Haynatzki; Rodney D McComb; Koji Uchida; Dimitrios Miserlis; Evlampia Papoutsi; Jason M Johanning; George P Casale; Iraklis I Pipinos
Journal:  J Surg Res       Date:  2015-02-13       Impact factor: 2.192

4.  Muscle strength and control characteristics are altered by peripheral artery disease.

Authors:  Molly N Schieber; Ryan M Hasenkamp; Iraklis I Pipinos; Jason M Johanning; Nicholas Stergiou; Holly K DeSpiegelaere; Jung H Chien; Sara A Myers
Journal:  J Vasc Surg       Date:  2017-07       Impact factor: 4.268

5.  Peripheral artery disease affects the function of the legs of claudicating patients in a diffuse manner irrespective of the segment of the arterial tree primarily involved.

Authors:  Todd J Leutzinger; Panagiotis Koutakis; Matthew A Fuglestad; Hafizur Rahman; Holly Despiegelaere; Mahdi Hassan; Molly Schieber; Jason M Johanning; Nick Stergiou; G Matthew Longo; George P Casale; Sara A Myers; Iraklis I Pipinos
Journal:  PLoS One       Date:  2022-07-13       Impact factor: 3.752

6.  Skeletal muscle MiR-210 expression is associated with mitochondrial function in peripheral artery disease patients.

Authors:  Ahmed Ismaeel; Emma Fletcher; Dimitrios Miserlis; Marissa Wechsler; Evlampia Papoutsi; Gleb Haynatzki; Robert S Smith; William T Bohannon; Panagiotis Koutakis
Journal:  Transl Res       Date:  2022-03-12       Impact factor: 10.171

7.  Muscle forces and power are significantly reduced during walking in patients with peripheral artery disease.

Authors:  Hafizur Rahman; Cody P Anderson; Iraklis I Pipinos; Jason M Johanning; George P Casale; Jianghu Dong; Holly DeSpiegelaere; Mahdi Hassan; Sara A Myers
Journal:  J Biomech       Date:  2022-02-25       Impact factor: 2.789

Review 8.  Cell therapy for peripheral artery disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Curr Opin Pharmacol       Date:  2018-02-13       Impact factor: 5.547

9.  Synthesis and characterization of a hyaluronic acid-based hydrogel with antioxidative and thermosensitive properties.

Authors:  Meng Chen; Cui Li; Fujiao Nie; Xiaoyan Liu; Iraklis I Pipinos; Xiaowei Li
Journal:  RSC Adv       Date:  2020-09-14       Impact factor: 4.036

Review 10.  Skeletal Muscle Pathology in Peripheral Artery Disease: A Brief Review.

Authors:  Mary M McDermott; Luigi Ferrucci; Marta Gonzalez-Freire; Kate Kosmac; Christiaan Leeuwenburgh; Charlotte A Peterson; Sunil Saini; Robert Sufit
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-09-17       Impact factor: 10.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.